COO Company Profile and Key Details

Q: Who are the executives of COO?

Mr. Juan Carlos AragonPres of CooperVision Specialty EyeCare DivisionMr. Agostino RicupatiSenior Vice President & Chief Accounting OfficerMr. Kim DuncanVice President of Investor Relations & Risk ManagementMr. Nicholas S. KhadderGen. Counsel & Corporation Sec.Mr. Albert G. White IIIPres, Chief Executive Officer & Non-Independent DirectorMr. Brian G. AndrewsExecutive Vice President, Chief Financial Officer & TreasurerMr. Daniel G. McBride Esq.Executive Vice President & Chief Operating OfficerMs. Holly R. SheffieldPres of CooperSurgical, Inc.Mr. Gerard H. Warner IIIPres of CooperVision, Inc.

NASDAQ : COO

Cooper Companies

$74.23

0.91+1.24%

At Close 4:00 PM

54.02

B-ESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

The Cooper Companies, Inc. (COO) stock surged +1.24%, trading at $74.23 on NASDAQ, up from the previous close of $73.32. The stock opened at $73.03, fluctuating between $72.65 and $74.58 in the recent session.

Stock Snapshot

73.32

Prev. Close

14.48B

Market Cap

72.65

Day Low

16.28

P/E Ratio

4.56

EPS (TTM)

0.69

Cash Flow per Share

73.03

Open

195.03M

Number of Shares

74.58

Day High

99%

Free Float in %

38.79

Book Value

1.53M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Aug 07, 2026	73.05	74.58	72.65	74.23	1.56M
Aug 06, 2026	75.00	75.13	73.23	73.32	1.93M
Aug 05, 2026	74.75	75.02	73.82	74.84	1.51M
Aug 04, 2026	73.91	74.80	73.27	74.69	1.97M
Aug 03, 2026	73.38	74.85	73.38	74.23	2.48M
Jul 31, 2026	71.95	72.51	71.15	72.32	2.52M
Jul 30, 2026	73.06	73.10	71.78	72.65	1.4M
Jul 29, 2026	71.50	73.09	71.43	73.06	1.72M
Jul 28, 2026	71.38	72.64	71.07	72.06	1.77M
Jul 27, 2026	70.82	71.63	70.26	70.29	2.17M
Jul 24, 2026	70.61	70.90	70.20	70.31	1.43M
Jul 23, 2026	70.11	70.74	69.60	70.23	2.05M
Jul 22, 2026	71.94	71.94	70.16	70.50	1.6M
Jul 21, 2026	70.61	71.61	70.20	71.01	2.26M
Jul 20, 2026	71.39	71.83	70.77	71.59	2.35M
Jul 17, 2026	73.10	73.94	71.45	71.71	1.67M
Jul 16, 2026	71.50	73.38	71.30	73.10	1.87M
Jul 15, 2026	68.71	71.60	68.60	70.60	1.92M
Jul 14, 2026	69.90	70.39	68.37	68.51	2.07M
Jul 13, 2026	71.09	71.85	70.71	71.32	1.71M

Contact Details

San Ramon, CA 94583

United States

https://www.coopercos.com 925 460 3600

About Company

The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.

Stock Peers

ATRI

0.26+0.06%

Atrion Corporation$459.92 ISRG

5.1+1.36%

Intuitive Surgical, Inc.$378.81 ICUI

18.19+10.93%

ICU Medical, Inc.$184.56 RGEN

4.46+2.80%

Repligen Corporation$163.90 MMSI

1.35+1.54%

Merit Medical Systems, Inc.$89.04 LMAT

0.63+0.78%

LeMaitre Vascular, Inc.$81.45 HOLX

0.0000020.00%

Hologic, Inc.$76.01 UTMD

0.86+1.23%

Utah Medical Products, Inc.$70.83 PDEX

0.08+0.12%

Pro-Dex, Inc.$65.56 PLSE

4.17+10.90%

Pulse Biosciences, Inc.$42.41

Company Overview

The Cooper Companies, Inc. (NASDAQ:COO) closed at $74.23 USD, gaining $0.91 (1.24%) from the previous close of $73.32. The stock is currently mid-range between its 52-week high and low $58.89 and $89.83. With a market capitalization of about $14.48 billion, The Cooper Companies, Inc. is classified as a large-cap and shows market-like volatility (beta ~0.84). Key stats such as the average daily volume over the past year has been around 2.82 million shares, volume is running light vs its 52-week average. Headquartered in San Ramon, CA, The Cooper Companies, Inc. operates in the Healthcare sector and the Medical - Instruments & Supplies industry. Led by CEO Albert G. White, the company employs approximately 15,000 people and listed since January 21, 1983. The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical.

Technical Performance

Short-term trend indicators are mixed aligned (SMA20 2.28%, SMA50 2.18%, SMA200 12.25%). The stock’s 14-day RSI is 57.88 (neutral), while the ATR of 1.83 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -9.51% below its high and over 35.99% above its low. Average 10-day trading volume of 1.89 million shares is below the 3-month average of 2.74 million, indicating normal recent market interest.

Valuation Metrics

The Cooper Companies, Inc. trades at a P/E ratio of 62.82, slightly above the S&P 500 average, with a price-to-sales ratio of 3.42 and a price-to-book ratio of 1.75 suggesting the stock is closer to book value. The P/FCF stands at 25.38, also above market averages.

Dividend & Fair Value

The Cooper Companies, Inc. last paid a dividend of 0.01 per share, this equals a trailing yield of roughly 0.01%. Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $52.92. This means the shares are trading above this model’s fair value.

Shareholding & Insider Activity

The Cooper Companies, Inc. has 195.03 million shares outstanding. The public float is 193.67 million shares, elevated short interest at 4.63% of float. This equals 7.92 million shares. The short ratio is 2.68 days. Institutional investors hold 107.01% of the float. Insiders own 0.61%. WEISS ROBERT S holds 282.77 thousand shares, White Albert G III has 236.15 thousand shares and McBride Daniel G has 63.12 thousand shares.

Financial & Profitability Overview

Over the trailing twelve months, Cooper Companies generated $4.09B in revenue, or $20.46 per share. Gross margin was 60.67%, operating margin 16.69%, and net profit margin 9.16%. Returns are modest, with ROA at 3.02% and ROE at 4.55%.
On valuation metrics, Cooper Companies trades at a P/E of 62.82, P/S of 3.42 and P/B of 1.75. The current ratio is 1.27 and quick ratio is 0.78. Operationally, the company’s inventory turnover is 1.68 and cash conversion cycle is 230.36 days. Debt-to-equity is 0.30, supported by a cash flow-to-debt ratio of 0.39.

Quarterly Financial Highlights

For the quarter ended Oct 31, 2025, Cooper Companies posted revenue of $4.09B, down slightly from $3.90B in the prior quarter. Gross profit was $2.48B (margin 60.67%). Operating income was $682.90M (margin 16.7%). Net income was$374.90M (EPS $1.87).
The company ended the quarter with $110.60M in cash and short-term investments, a total debt of $2.78B, and net debt of $2.67B. Total assets were $12.39B, with equity of $8.24B. Financials further reflected stability, with operating cash flow of $796.10M, free cash flow of $433.70M, and capital expenditures of - $362.40M.

Price Forecast & Outlook

Our AI price prediction model suggests that The Cooper Companies, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 4.67%, with price expected at $77.70 by August 21, 2026, within a range of $76.00 to $79.39 3-Month Outlook: Projected rise of 48.3%, reaching $110.08 by November 04, 2026, with a range of $104.41 to $115.53. 1-Year Outlook: Projected loss of -11.73%, with price at $65.52 by August 06, 2027, within a range of $61.49 to $68.59.

Key Takeaways

The Cooper Companies, Inc. (NASDAQ:COO) shares are flat -1.65% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows The Cooper Companies, Inc. trading at a premium to the broader market with a P/E of 62.82. Analyst sentiment is mixed, with the majority of ratings in Neutral territory and a mean price target of $195.41, suggesting 163.25% upside. Our AI forecast model points to short-term strength (4.67% over two weeks), a medium-term rise (48.3% over three months), and a longer-term loss (-11.73% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current The Cooper Companies, Inc. (COO) stock price?

The Cooper Companies, Inc. (NASDAQ: COO) stock price is $74.23 in the last trading session. During the trading session, COO stock reached the peak price of $74.58 while $72.65 was the lowest point it dropped to. The percentage change in COO stock occurred in the recent session was 1.24% while the dollar amount for the price change in COO stock was $0.91.

COO's industry and sector of operation?

The NASDAQ listed COO is part of Medical - Instruments & Supplies industry that operates in the broader Healthcare sector. The Cooper Companies, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of COO?

Mr. Juan Carlos Aragon
Pres of CooperVision Specialty EyeCare Division
Mr. Agostino Ricupati
Senior Vice President & Chief Accounting Officer
Mr. Kim Duncan
Vice President of Investor Relations & Risk Management
Mr. Nicholas S. Khadder
Gen. Counsel & Corporation Sec.
Mr. Albert G. White III
Pres, Chief Executive Officer & Non-Independent Director
Mr. Brian G. Andrews
Executive Vice President, Chief Financial Officer & Treasurer
Mr. Daniel G. McBride Esq.
Executive Vice President & Chief Operating Officer
Ms. Holly R. Sheffield
Pres of CooperSurgical, Inc.
Mr. Gerard H. Warner III
Pres of CooperVision, Inc.

How COO did perform over past 52-week?

COO's closing price is 26.05% higher than its 52-week low of $58.89 where as its distance from 52-week high of $89.83 is -17.37%.

How many employees does COO have?

Number of COO employees currently stands at 15,000.

Link for COO official website?

Official Website of COO is: https://www.coopercos.com

How do I contact COO?

COO could be contacted at phone 925 460 3600 and can also be accessed through its website. COO operates from 6101 Bollinger Canyon Road, San Ramon, CA 94583, United States.

How many shares of COO are traded daily?

COO stock volume for the day was 1.53M shares. The average number of COO shares traded daily for last 3 months was 2.82M.

What is the market cap of COO currently?

The market value of COO currently stands at $14.48B with its latest stock price at $74.23 and 195.03M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	15000
Beta	0.84
Sales or Revenue	$4.09B
5Y Sales Change%	-0.587%
Fiscal Year Ends	October
Sector	Healthcare
Industry	Medical - Instruments & Supplies

COO Company Profile and Key Details

Cooper Companies

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Shareholding & Insider Activity

Company Overview

Dividend & Fair Value

Financial & Profitability Overview

Quarterly Financial Highlights

Valuation Metrics

Key Takeaways

Price Forecast & Outlook